MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS)*
Organization & Developments: Acumen Pharmaceuticals
Parents
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS)*
Children
2022: Acumen Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: Acumen: ACU193 Is A Promising Phase 1 Alzheimer's Candidate, But Not More Than That_ seekingalpha.com
2023: Acumen Pharmaceuticals: Novel Alzheimer's Molecule With Positive Early Data
2023: Navigating Acumen's Alzheimer's Risk And Reward (NASDAQ:ABUS)
2024: Acumen Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
Early-stage, drug discovery company committed to developing novel, disease-modifying therapeutics
Mild cognitive impairment
Jumps
Finance & Acquisition: Acumen Pharmaceuticals
Key People: Acumen Pharmaceuticals